{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,6]],"date-time":"2026-06-06T15:39:35Z","timestamp":1780760375114,"version":"3.54.1"},"reference-count":38,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"13","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2018,7,5]]},"DOI":"10.4103\/0366-6999.235113","type":"journal-article","created":{"date-parts":[[2018,6,26]],"date-time":"2018-06-26T12:06:43Z","timestamp":1530014803000},"page":"1575-1583","source":"Crossref","is-referenced-by-count":4,"title":["Identification of a Novel Homozygous Splice-Site Mutation in SCARB2 that Causes Progressive Myoclonus Epilepsy with or without Renal Failure"],"prefix":"10.1097","volume":"131","author":[{"given":"Jin","family":"He","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Han","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jin-Jing","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hui-Zhen","family":"Su","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dan-Ni","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ning","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wan-Jin","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-10-20210129","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1055\/s-0035-1552620","article-title":"Progressive myoclonus epilepsies","volume":"35","author":"K\u00e4lvi\u00e4inen","year":"2015","journal-title":"Semin Neurol"},{"key":"R3-10-20210129","doi-asserted-by":"crossref","first-page":"946","DOI":"10.1038\/sj.ejhg.5200571","article-title":"Mutational spectrum of the EPM2A gene in progressive myoclonus epilepsy of Lafora: High degree of allelic heterogeneity and prevalence of deletions","volume":"8","author":"G\u00f3mez-Garre","year":"2000","journal-title":"Eur J Hum Genet"},{"key":"R4-10-20210129","doi-asserted-by":"crossref","first-page":"982","DOI":"10.1212\/01.WNL.0000154519.10805.F7","article-title":"Lafora disease due to EPM2B mutations: A clinical and genetic study","volume":"64","author":"G\u00f3mez-Abad","year":"2005","journal-title":"Neurology"},{"key":"R5-10-20210129","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1093\/brain\/awh377","article-title":"A new clinical and molecular form of Unverricht-Lundborg disease localized by homozygosity mapping","volume":"128","author":"Berkovic","year":"2005","journal-title":"Brain"},{"key":"R6-10-20210129","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1007\/s10038-005-0263-7","article-title":"Mutations in the NHLRC1 gene are the common cause for Lafora disease in the Japanese population","volume":"50","author":"Singh","year":"2005","journal-title":"J Hum Genet"},{"key":"R7-10-20210129","doi-asserted-by":"crossref","first-page":"1016","DOI":"10.1002\/mds.22489","article-title":"Description of a family with a novel progressive myoclonus epilepsy and cognitive impairment","volume":"24","author":"Ferlazzo","year":"2009","journal-title":"Mov Disord"},{"key":"R8-10-20210129","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1016\/j.ajhg.2011.04.011","article-title":"A mutation in the Golgi qb-SNARE gene GOSR2 causes progressive myoclonus epilepsy with early ataxia","volume":"88","author":"Corbett","year":"2011","journal-title":"Am J Hum Genet"},{"key":"R9-10-20210129","doi-asserted-by":"crossref","first-page":"2684","DOI":"10.1093\/brain\/aws205","article-title":"Early-onset Lafora body disease","volume":"135","author":"Turnbull","year":"2012","journal-title":"Brain"},{"key":"R10-10-20210129","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/j.eplepsyres.2011.09.020","article-title":"Four novel and two recurrent NHLRC1 (EPM2B) and EPM2A gene mutations leading to Lafora disease in six Turkish families","volume":"98","author":"Salar","year":"2012","journal-title":"Epilepsy Res"},{"key":"R11-10-20210129","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1136\/jmedgenet-2012-100859","article-title":"Novel mutations consolidate KCTD7 as a progressive myoclonus epilepsy gene","volume":"49","author":"Kousi","year":"2012","journal-title":"J Med Genet"},{"key":"R12-10-20210129","doi-asserted-by":"crossref","first-page":"4483","DOI":"10.1093\/hmg\/ddv171","article-title":"Mutation of the nuclear lamin gene LMNB2 in progressive myoclonus epilepsy with early ataxia","volume":"24","author":"Damiano","year":"2015","journal-title":"Hum Mol Genet"},{"key":"R13-10-20210129","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1038\/ng.3144","article-title":"A recurrent de novo mutation in KCNC1 causes progressive myoclonus epilepsy","volume":"47","author":"Muona","year":"2015","journal-title":"Nat Genet"},{"key":"R14-10-20210129","doi-asserted-by":"crossref","first-page":"2881e11","DOI":"10.1016\/j.neurobiolaging.2014.07.003","article-title":"Identify mutation in amyotrophic lateral sclerosis cases using HaloPlex target enrichment system","volume":"35","author":"Liu","year":"2014","journal-title":"Neurobiol Aging"},{"key":"R15-10-20210129","doi-asserted-by":"crossref","first-page":"27655","DOI":"10.18632\/oncotarget.8377","article-title":"Improving molecular diagnosis of Chinese patients with Charcot-Marie-tooth by targeted next-generation sequencing and functional analysis","volume":"7","author":"Li","year":"2016","journal-title":"Oncotarget"},{"key":"R16-10-20210129","doi-asserted-by":"crossref","first-page":"2508","DOI":"10.4103\/0366-6999.191829","article-title":"Late-onset juvenile myoclonic epilepsy or frontal lobe epilepsy with myoclonus","volume":"129","author":"Zhang","year":"2016","journal-title":"Chin Med J"},{"key":"R17-10-20210129","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1038\/ng0194-9","article-title":"Unstable expansion of CAG repeat in hereditary dentatorubral-pallidoluysian atrophy (DRPLA)","volume":"6","author":"Koide","year":"1994","journal-title":"Nat Genet"},{"key":"R18-10-20210129","doi-asserted-by":"crossref","first-page":"2238","DOI":"10.1093\/hmg\/ddn124","article-title":"A nonsense mutation in the LIMP-2 gene associated with progressive myoclonic epilepsy and nephrotic syndrome","volume":"17","author":"Balreira","year":"2008","journal-title":"Hum Mol Genet"},{"key":"R19-10-20210129","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1016\/j.ajhg.2007.12.019","article-title":"Array-based gene discovery with three unrelated subjects shows SCARB2\/LIMP-2 deficiency causes myoclonus epilepsy and glomerulosclerosis","volume":"82","author":"Berkovic","year":"2008","journal-title":"Am J Hum Genet"},{"key":"R20-10-20210129","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/j.ymgme.2009.04.011","article-title":"Biochemical and molecular findings in a patient with myoclonic epilepsy due to a mistarget of the beta-glucosidase enzyme","volume":"97","author":"Dardis","year":"2009","journal-title":"Mol Genet Metab"},{"key":"R21-10-20210129","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1002\/ana.21765","article-title":"SCARB2 mutations in progressive myoclonus epilepsy (PME) without renal failure","volume":"66","author":"Dibbens","year":"2009","journal-title":"Ann Neurol"},{"key":"R22-10-20210129","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1001\/archneurol.2011.120","article-title":"Mutation of SCARB2 in a patient with progressive myoclonus epilepsy and demyelinating peripheral neuropathy","volume":"68","author":"Dibbens","year":"2011","journal-title":"Arch Neurol"},{"key":"R23-10-20210129","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1186\/1471-2377-11-134","article-title":"Novel SCARB2 mutation in action myoclonus-renal failure syndrome and evaluation of SCARB2 mutations in isolated AMRF features","volume":"11","author":"Hopfner","year":"2011","journal-title":"BMC Neurol"},{"key":"R24-10-20210129","doi-asserted-by":"crossref","first-page":"1200","DOI":"10.1002\/mds.25083","article-title":"A case of severe hearing loss in action myoclonus renal failure syndrome resulting from mutation in SCARB2","volume":"27","author":"Perandones","year":"2012","journal-title":"Mov Disord"},{"key":"R25-10-20210129","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1111\/nan.12057","article-title":"Progressive myoclonus epilepsy: Extraneuronal brown pigment deposition and system neurodegeneration in the brains of japanese patients with novel SCARB2 mutations","volume":"40","author":"Fu","year":"2014","journal-title":"Neuropathol Appl Neurobiol"},{"key":"R26-10-20210129","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1111\/cge.12338","article-title":"Using a combination of whole-exome sequencing and homozygosity mapping to identify a novel mutation of SCARB2","volume":"86","author":"He","year":"2014","journal-title":"Clin Genet"},{"key":"R27-10-20210129","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1016\/j.jns.2014.01.022","article-title":"A novel SCARB2 mutation in progressive myoclonus epilepsy indicated by reduced \u03b2-glucocerebrosidase activity","volume":"339","author":"Zeigler","year":"2014","journal-title":"J Neurol Sci"},{"key":"R28-10-20210129","doi-asserted-by":"crossref","first-page":"1826","DOI":"10.1002\/mds.25114","article-title":"A new SCARB2 mutation in a patient with progressive myoclonus ataxia without renal failure","volume":"27","author":"Guerrero-L\u00f3pez","year":"2012","journal-title":"Mov Disord"},{"key":"R29-10-20210129","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1002\/mds.25296","article-title":"A novel SCARB2 mutation causing late-onset progressive myoclonus epilepsy","volume":"28","author":"Higashiyama","year":"2013","journal-title":"Mov Disord"},{"key":"R30-10-20210129","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1002\/mds.25738","article-title":"A new SCARB2 mutation in a patient with progressive myoclonus ataxia without renal failure","volume":"29","author":"Perandones","year":"2014","journal-title":"Mov Disord"},{"key":"R31-10-20210129","doi-asserted-by":"crossref","first-page":"e1002141","DOI":"10.1371\/journal.pgen.1002141","article-title":"Web-based genome-wide association study identifies two novel loci and a substantial genetic component for Parkinson's disease","volume":"7","author":"Do","year":"2011","journal-title":"PLoS Genet"},{"key":"R32-10-20210129","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1002\/mds.24886","article-title":"Evidence of an association between the scavenger receptor class B member 2 gene and Parkinson's disease","volume":"27","author":"Michelakakis","year":"2012","journal-title":"Mov Disord"},{"key":"R33-10-20210129","first-page":"4117","article-title":"A role for the lysosomal membrane protein LGP85 in the biogenesis and maintenance of endosomal and lysosomal morphology","volume":"115","author":"Kuronita","year":"2002","journal-title":"J Neurol Sci"},{"key":"R34-10-20210129","doi-asserted-by":"crossref","first-page":"15573","DOI":"10.1073\/pnas.1405700111","article-title":"LIMP-2 expression is critical for \u03b2-glucocerebrosidase activity and \u03b1-synuclein clearance","volume":"111","author":"Rothaug","year":"2014","journal-title":"Proc Natl Acad Sci U S A"},{"key":"R35-10-20210129","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1016\/j.cell.2007.10.018","article-title":"LIMP-2 is a receptor for lysosomal mannose-6-phosphate-independent targeting of beta-glucocerebrosidase","volume":"131","author":"Reczek","year":"2007","journal-title":"Cell"},{"key":"R36-10-20210129","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1093\/hmg\/ddp523","article-title":"Disease-causing mutations within the lysosomal integral membrane protein type 2 (LIMP-2) reveal the nature of binding to its ligand beta-glucocerebrosidase","volume":"19","author":"Blanz","year":"2010","journal-title":"Hum Mol Genet"},{"key":"R37-10-20210129","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1038\/nature12684","article-title":"Structure of LIMP-2 provides functional insights with implications for SR-BI and CD36","volume":"504","author":"Neculai","year":"2013","journal-title":"Nature"},{"key":"R38-10-20210129","doi-asserted-by":"crossref","first-page":"30063","DOI":"10.1074\/jbc.M114.593616","article-title":"The LIMP-2\/SCARB2 binding motif on acid \u03b2-glucosidase: basic and applied implications for Gaucher disease and associated neurodegenerative diseases","volume":"289","author":"Liou","year":"2014","journal-title":"J Biol Chem"},{"key":"R39-10-20210129","doi-asserted-by":"crossref","first-page":"3839","DOI":"10.1096\/fj.15-271148","article-title":"Role of LIMP-2 in the intracellular trafficking of \u03b2-glucosidase in different human cellular models","volume":"29","author":"Malini","year":"2015","journal-title":"FASEB J"}],"container-title":["Chinese Medical Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.4103\/0366-6999.235113","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,6,17]],"date-time":"2021-06-17T19:48:03Z","timestamp":1623959283000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00029330-201807050-00010"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,7,5]]},"references-count":38,"journal-issue":{"issue":"13","published-print":{"date-parts":[[2018]]}},"URL":"https:\/\/doi.org\/10.4103\/0366-6999.235113","relation":{},"ISSN":["0366-6999"],"issn-type":[{"value":"0366-6999","type":"print"}],"subject":[],"published":{"date-parts":[[2018,7,5]]}}}